Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.
Also called NCT01332747
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 128 participants
- Sponsor
- Jamia Hamdard University
- Registry
-
NCT01332747
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT01332747. Randomized; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2011-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation
- Condition
- Hyperlipidemia
- Intervention (Drug)
- safoof e muhazzil
- Intervention (Drug)
- compressed tablet of safoof e muhazzil
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Jamia Hamdard University
Record details
- Record id
cardio:ct-nct01332747- Content hash
f4c9886be04956455b2efe2b6770f626c1c355f324968829a27071251a8b1a10